Impact of number of episodes on neurocognitive trajectory in bipolar disorder patients: a 5-year follow-up study.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 26 7 2018
medline: 15 5 2020
entrez: 26 7 2018
Statut: ppublish

Résumé

The neurocognitive trajectory in bipolar disorder (BD) is variable, with controversial findings, and most evidence come from cross-sectional studies. We aimed to examine the course of neurocognitive functioning in a sample of euthymic BD patients in comparison with a control group during a 5-year follow-up. Ninety-nine euthymic bipolar patients and 40 healthy controls were assessed using a comprehensive neurocognitive battery (six neurocognitive domains) at baseline (T1) and then at 5-year follow-up (T2) in a longitudinal study. No evidence of a progression in neurocognitive dysfunction was found either in cognitive composite index or in any of the neurocognitive domains for the whole cohort. However, there was a negative correlation between number of manic episodes and hospitalisations due to manic episodes and change in neurocognitive composite index (NCI) during the follow-up. Moreover, patients with higher number of manic and hypomanic episodes have a greater decrease in NCI, working memory and visual memory. History of psychotic symptoms was not related to the trajectory of neurocognitive impairment. Our results suggest that, although the progression of cognitive decline is not a general rule in BD, BD patients who have a greater number of manic or hypomanic episodes may constitute a subgroup characterised by the progression of neurocognitive impairment. Prevention of manic and hypomanic episodes could have a positive impact on the trajectory of cognitive function.

Sections du résumé

BACKGROUND
The neurocognitive trajectory in bipolar disorder (BD) is variable, with controversial findings, and most evidence come from cross-sectional studies. We aimed to examine the course of neurocognitive functioning in a sample of euthymic BD patients in comparison with a control group during a 5-year follow-up.
METHODS
Ninety-nine euthymic bipolar patients and 40 healthy controls were assessed using a comprehensive neurocognitive battery (six neurocognitive domains) at baseline (T1) and then at 5-year follow-up (T2) in a longitudinal study.
RESULTS
No evidence of a progression in neurocognitive dysfunction was found either in cognitive composite index or in any of the neurocognitive domains for the whole cohort. However, there was a negative correlation between number of manic episodes and hospitalisations due to manic episodes and change in neurocognitive composite index (NCI) during the follow-up. Moreover, patients with higher number of manic and hypomanic episodes have a greater decrease in NCI, working memory and visual memory. History of psychotic symptoms was not related to the trajectory of neurocognitive impairment.
CONCLUSIONS
Our results suggest that, although the progression of cognitive decline is not a general rule in BD, BD patients who have a greater number of manic or hypomanic episodes may constitute a subgroup characterised by the progression of neurocognitive impairment. Prevention of manic and hypomanic episodes could have a positive impact on the trajectory of cognitive function.

Identifiants

pubmed: 30043716
pii: S0033291718001885
doi: 10.1017/S0033291718001885
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1299-1307

Auteurs

Eva María Sánchez-Morla (EM)

Department of Psychiatry,Research Institute of Hospital 12 de Octubre (imas12),Madrid,Spain.

Ana López-Villarreal (A)

Department of Psychiatry,Hospital Virgen de La Luz,Cuenca,Spain.

Estela Jiménez-López (E)

CIBERSAM (Biomedical Research Networking Centre in Mental Health),Spain.

Ana Isabel Aparicio (AI)

CIBERSAM (Biomedical Research Networking Centre in Mental Health),Spain.

Vicente Martínez-Vizcaíno (V)

Health and Social Research Center, Universidad de Castilla-La Mancha,Cuenca,Spain.

Rodriguez-Jimenez Roberto (RJ)

Department of Psychiatry,Research Institute of Hospital 12 de Octubre (imas12),Madrid,Spain.

Eduard Vieta (E)

CIBERSAM (Biomedical Research Networking Centre in Mental Health),Spain.

José-Luis Santos (JL)

CIBERSAM (Biomedical Research Networking Centre in Mental Health),Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH